Effects of Polymannuronic Acid on the Intestinal Microbiota in Mice after Long-Term Intragastric Administration

E Zhang,Qiang Wei,Xia Li,Shuliang Song
DOI: https://doi.org/10.3390/md22030125
2024-03-07
Marine Drugs
Abstract:Polymannuronic acid (PM) is an alginate oligosaccharide derived from brown algae with a characterized structure and excellent biological activities. Herein, mice were given different doses of PM through 30-day-long-term intragastric administration, and the contents of the jejunum, ileum, and colon were analyzed by 16S rRNA gene sequencing technology for microbial diversity, and relevant experiments were verified according to the analysis results so as to comprehensively evaluate the effects of PM on the intestinal flora. The PM (400 mg/kg and 100 mg/kg) could regulate the microflora balance at the phylum level and increase the microflora richness in the jejunum, ileum, and colon of the mice. The PM could induce more strains that are negatively correlated with Escherichia, thereby reducing the relative abundance of Escherichia. Analysis of bacterial function showed that high and low doses of PM could promote lipid metabolism in the bacterial communities. Moreover, the PM could reduce serum total cholesterol and cholesterol ester levels in a concentration-dependent manner. High-dose PM could lead to colonic intestinal inflammation by increasing the relative abundance of multiple bacterial groups in the jejunum, ileum, and colon. Moreover, high-dose PM could increase lipopolysaccharide-binding protein and interleukin-1β levels. Therefore, the dose of PM plays an important role in its efficacy, and its biological activity is dosedifferent.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the effect of long - term oral administration of polymannuronic acid (PM) on the gut microbiota of mice. Specifically, through 30 - day long - term intragastric administration, the study analyzed the effects of different doses of PM on microbial diversity and related functions in the jejunum, ileum and colon contents of mice. The main concerns include: 1. **Changes in microbial diversity**: Analyze the regulatory effect of PM on the structure and diversity of the gut microbial community in mice by 16S rRNA gene sequencing technology. 2. **Changes in microbial function**: Explore the effect of PM on the metabolic function of gut microbiota, especially the changes in lipid metabolism. 3. **Dose - dependent effects**: Evaluate the specific effects of different doses (100 mg/kg and 400 mg/kg) of PM on the gut microbial community, including the regulatory effect on specific flora and its potential biological significance. 4. **Safety assessment**: Observe the effects of long - term administration of PM on physiological indicators such as body weight, fecal water content and organ index of mice to evaluate its safety. Through these analyses, the study aims to comprehensively evaluate the comprehensive effects of long - term oral administration of polymannuronic acid on the gut microbiota of mice, and provide experimental basis for its further pharmacological research and clinical application.